(Total Views: 675)
Posted On: 05/07/2020 9:13:11 PM
Post# of 153908
Of course the BLA was filed when the PR said it was... and the FDA must have asked for an update, that's all.
Tonight's PR is not the first to have :
The BLA submission PR came out on Monday April 27th and there have been six more PRs since (one of six came out same day 4/27).
The last two PRs have the same statement in them (above quote):
5/6/2020 PR:
https://www.cytodyn.com/newsroom/press-releas...b-disrupts
5/4/2020 PR:
https://www.cytodyn.com/newsroom/press-releas...eatment-of
Posted this on other board also...
Tonight's PR is not the first to have :
Quote:
We would like to provide an update that the Biologics License Application (BLA) for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients will be considered completed after the clinical datasets are submitted on May 11, 2020.
The BLA submission PR came out on Monday April 27th and there have been six more PRs since (one of six came out same day 4/27).
The last two PRs have the same statement in them (above quote):
5/6/2020 PR:
https://www.cytodyn.com/newsroom/press-releas...b-disrupts
5/4/2020 PR:
https://www.cytodyn.com/newsroom/press-releas...eatment-of
Posted this on other board also...
(2)
(0)
